Rep. Chris Collins, the New York lawmaker facing insider trading charges, was once the No. 2 shareholder in an Australian firm called Innate Immunotherapeutics. According to the company’s most recent disclosure, he’s no longer even in the top 20 shareholders.
What’s unclear is what happened to his shares.
About the Author Reprints
Can you complete a Congressional term while incarcerated?